What Is Vitamin D

Vitamin D is a fat-soluble secosteroid that functions as a hormone precursor, regulating calcium and phosphorus metabolism, immune responses, and the expression of over a thousand genes. The body synthesizes it in the skin upon exposure to ultraviolet B radiation, but it can also be obtained from a small number of foods and from supplements. Once activated through two hydroxylation steps in the liver and kidneys, it binds nuclear receptors in nearly every tissue type.

Adequate vitamin D status correlates with lower all-cause mortality in large epidemiological cohorts, and deficiency is one of the most widespread nutritional insufficiencies worldwide. Beyond its classical role in preventing rickets and osteoporosis, vitamin D influences processes central to aging: immune surveillance, inflammatory tone, insulin sensitivity, cardiovascular remodeling, and cellular proliferation control. These are not peripheral concerns; they map directly onto the major causes of disability and death in older adults.

For longevity, the relevance is twofold. First, maintaining sufficient levels supports the structural integrity of bone and muscle, helping preserve mobility and reduce fracture risk as decades pass. Second, the hormone's immunomodulatory actions may shape resilience against infections, autoimmune dysregulation, and chronic low-grade inflammation, a cluster of vulnerabilities that accelerates biological aging. Given that deficiency is both common and correctable, vitamin D represents one of the more accessible levers in a longevity-oriented health strategy.

When UV-B photons strike the skin, they convert 7-dehydrocholesterol in the epidermis into pre-vitamin D3, which isomerizes to cholecalciferol (vitamin D3). This molecule is biologically inert. It travels via binding protein in the bloodstream to the liver, where the enzyme CYP2R1 hydroxylates it into 25-hydroxyvitamin D (calcidiol), the form measured in standard blood tests. Calcidiol then undergoes a second hydroxylation in the kidneys (and in many other tissues locally) by CYP27B1 to become 1,25-dihydroxyvitamin D (calcitriol), the active hormonal form.

Calcitriol binds the vitamin D receptor (VDR), a nuclear transcription factor present in cells of the intestine, bone, kidney, pancreas, immune system, brain, and cardiovascular system. In the intestine, VDR activation upregulates calcium-binding proteins that increase dietary calcium absorption by two- to fourfold. In bone, it orchestrates the balance between osteoblast-driven formation and osteoclast-driven resorption. In immune cells, calcitriol enhances innate antimicrobial peptide production (notably cathelicidin) while modulating adaptive immune responses, shifting T-helper cell balance and supporting regulatory T-cell development.

Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) form a feedback loop with calcitriol to keep serum calcium and phosphorus within tight limits. When vitamin D status is low, PTH rises to compensate by pulling calcium from bone, a process that over years contributes to osteoporosis. Beyond mineral homeostasis, VDR signaling influences cell cycle regulation, apoptosis, and angiogenesis, pathways relevant to cancer biology and tissue repair. The breadth of VDR distribution explains why vitamin D insufficiency has been linked to such a wide range of clinical conditions.

Vitamin D3 (cholecalciferol) is the preferred supplemental form due to its superior ability to raise and maintain serum 25-hydroxyvitamin D compared to vitamin D2 (ergocalciferol). D3 is available in softgels, liquid drops, capsules, tablets, and sublingual sprays. Softgels and liquid drops suspended in oil (often MCT or olive oil) tend to offer better absorption because vitamin D is fat-soluble and requires dietary fat for intestinal uptake. Taking it with the largest fat-containing meal of the day can further improve bioavailability.

D2, derived from irradiated ergosterol in fungi, is sometimes used in prescription formulations and is the form found in UV-exposed mushrooms. It undergoes the same hydroxylation pathway but binds vitamin D-binding protein less efficiently and is cleared from circulation faster. For people seeking plant-based options, lichen-sourced D3 supplements are now available and provide cholecalciferol without animal-derived ingredients.

Some formulations combine vitamin D3 with vitamin K2 (menaquinone-7) in a single softgel or drop, simplifying the common co-supplementation protocol. Emulsified and micellized liquid forms are marketed for enhanced absorption in individuals with fat malabsorption conditions, though comparative clinical trial data on these delivery technologies remain limited.

Dosing requirements vary substantially depending on baseline status, body composition, skin pigmentation, geographic latitude, and individual absorption capacity. The Endocrine Society has suggested that adults with deficiency may need 6,000 IU daily for eight weeks to reach sufficiency, followed by a maintenance dose of 1,500 to 2,000 IU daily, though many functional and integrative practitioners use individualized approaches guided by serial blood testing. Obese individuals often require two to three times the standard dose because adipose tissue sequesters the vitamin, reducing its circulating availability.

Large intermittent bolus dosing (for example, 50,000 IU weekly or 300,000 IU as a single injection) was once common but has fallen out of favor in clinical practice. Trial data suggest that bolus protocols are less effective at reducing respiratory infections and may paradoxically increase fall risk in elderly populations, possibly due to erratic fluctuations in active metabolite levels. Consistent daily or weekly dosing produces steadier serum concentrations and appears to yield better clinical outcomes.

The goal of dosing is to reach and maintain a target serum 25-hydroxyvitamin D level rather than to follow a fixed milligram amount. This makes periodic testing essential. Two individuals taking identical doses can end up with very different blood levels, so dose adjustments based on lab results are the norm rather than the exception.

When selecting a vitamin D3 supplement, third-party testing verification is a useful quality signal. Labels from organizations such as USP, NSF International, or ConsumerLab indicate that the product has been independently tested for label accuracy, purity, and absence of common contaminants like heavy metals or microbial contamination. Because vitamin D supplements are relatively simple molecules, adulteration is less of a concern than with botanical products, but label claim accuracy (the actual IU per serving matching what is stated) does vary among brands.

Oil-based softgels or liquid drops are generally preferable to dry tablet forms for bioavailability reasons, and products that specify the fat carrier used (MCT oil, olive oil, or coconut oil) provide more transparency. For individuals with dairy sensitivities or strict dietary requirements, checking for the absence of fillers, artificial colors, and common allergens is practical. Lichen-derived D3 products should specify their source clearly, as some "plant-based" labels are misleading. Storing vitamin D away from heat and direct light preserves potency, since the molecule degrades with prolonged exposure to either.

The evidence base for vitamin D is unusually large but also unusually complicated. Observational studies consistently associate low 25-hydroxyvitamin D levels with higher rates of cardiovascular disease, cancer, autoimmune conditions, respiratory infections, and all-cause mortality. However, large randomized controlled trials designed to test supplementation in generally healthy, vitamin D-replete populations have produced more modest results. A major multi-year trial involving tens of thousands of participants found that vitamin D3 supplementation did not significantly reduce the incidence of invasive cancer or major cardiovascular events in the overall study population, though subgroup analyses suggested possible benefits in cancer mortality after longer follow-up and among individuals with lower baseline levels or normal body weight.

Trials focusing on populations that are clearly deficient have shown more consistent benefits, particularly for bone health, fall prevention in the elderly, and reduction in acute respiratory infections. Meta-analyses of respiratory infection trials indicate a protective effect, especially with daily or weekly dosing rather than large intermittent boluses. The disconnect between observational and interventional data may partly reflect reverse causation (illness lowers vitamin D rather than vice versa) and partly the difficulty of detecting effects when enrolling participants who already have sufficient levels. What remains well established is that correcting deficiency provides measurable benefits, while the case for pharmacological dosing in replete individuals is unresolved.

Vitamin D toxicity, though rare with standard supplementation, can occur with prolonged intake above 10,000 IU daily without monitoring, leading to hypercalcemia, kidney stones, and vascular calcification. Individuals with granulomatous diseases (sarcoidosis, certain lymphomas) are at higher risk because their immune cells produce calcitriol unregulated by normal feedback mechanisms. High-dose supplementation without adequate vitamin K2 and magnesium may theoretically contribute to inappropriate calcium deposition. People taking thiazide diuretics, cardiac glycosides, or those with primary hyperparathyroidism should have levels monitored carefully, as interactions can amplify calcium-related risks. Routine blood testing makes toxicity largely preventable.